NCT06722508 Exercise and Nutritional Prehabilitation for Head and Neck Cancer Patients
| NCT ID | NCT06722508 |
| Status | Recruiting |
| Phase | — |
| Sponsor | University of California, Davis |
| Condition | Head Cancer |
| Study Type | INTERVENTIONAL |
| Enrollment | 20 participants |
| Start Date | 2024-05-09 |
| Primary Completion | 2026-12 |
Eligibility & Interventions
Eligibility Fast-Check
Enter your details for a quick preliminary check. This does not replace medical advice.
What to Expect as a Participant
You will actively receive the study intervention — which may be a drug, biologic, device, or procedure.
This trial targets 20 participants in total. It began in 2024-05-09 with a primary completion date of 2026-12.
⚠ This information is for research awareness only. Always consult your physician before joining any clinical trial. Participation is voluntary and you may withdraw at any time.
Brief Summary
This study examines the acceptability, feasibility, and safety in developing a prehabilitation program for head and neck cancer patients. The purpose of this research is to access the safety and acceptability of using a prehabilitation program before head and neck cancer surgery.
Eligibility Criteria
Inclusion Criteria: New head and neck cancer diagnosis Age \> 18 Exclusion Criteria: 1. Prior treatment for head and neck cancer (surgery and/or radiation) 2. Acute or unstable cardiac conditions (unstable angina or symptomatic severe aortic stenosis) 3. American Society of Anesthesiologists physical status of 4 and 5 4. Disabling orthopedic or neuromuscular disease 5. Cardiac failure (New York Heart Association functional classes III and IV) 6. Severe chronic obstructive pulmonary disease 7. End-stage liver or kidney disease 8. Inability to swallow and/or feeding tube dependence 9. Any other comorbid medical, physical, and/or mental condition that contraindicates exercise or oral nutrition 10. Adults unable to consent 11. Age 17.99 or younger 12. Prisoners, pregnant women, or other vulnerable population
Contact & Investigator
Marianne S Abouyared, MD
PRINCIPAL INVESTIGATOR
University of California, Davis
Frequently Asked Questions
Who can join the NCT06722508 clinical trial?
This trial is open to participants of all sexes, aged 18 Years or older, studying Head Cancer. Full inclusion and exclusion criteria are listed in the Eligibility Criteria section. Always confirm your eligibility with the research team before applying.
Is NCT06722508 currently recruiting?
Yes, NCT06722508 is actively recruiting participants. Contact the research team at rssandhu@ucdavis.edu for enrollment information.
Where is the NCT06722508 trial being conducted?
This trial is being conducted at Sacramento, United States, Sacramento, United States.
Who is sponsoring the NCT06722508 clinical trial?
NCT06722508 is sponsored by University of California, Davis. The principal investigator is Marianne S Abouyared, MD at University of California, Davis. The trial plans to enroll 20 participants.
Related Trials
Related Intelligence Guides
In-depth guides covering this condition's trials, eligibility, and what to expect.